Health Industry News
Kids Smart rescuing Aussie mums from formula shortage – November 12, 2015
As high quality, Australian-made, infant and toddler formula continues to fly off retail shelves, Australia’s market leading children’s supplement brand*, Kids Smart, is coming to the rescue. Today’s launch of Kids Smart Infant Formula and Toddler Milk, available exclusively to Chemist Warehouse nation-wide, should help curb the spiralling Chinese and local demand for trusted, home-grown…
Read MoreHow to mount a quick & safe recovery from injury – a physiotherapist’s advice – November 5, 2015
Words by Lyndsey Henderson – Senior Physiotherapist and Director of My Mobile Physio. Many of us rely on our ability to exercise in order to remain fit and healthy, manage stress and maintain good mental health. So when injury strikes, it can be incredibly frustrating, as the inability to maintain a regular exercise routine can…
Read MoreParasite-killing medications fighting malaria & blindness recognised in 2015 Nobel Prize winners in Physiology & Medicine
Professional role (e.g. Medical scientists), Satoshi Omura and William Campbell, and researcher, Youyou Tu have all clinched this year’s prestigious Nobel Prize for their work in the discovery of life-saving medicines. Discovering the bacteria, Steptomyces, Japanese microbiologist, Satoshi Omura was able to isolate samples of the bacteria, known to produce antibacterial agents, which he then…
Read MoreHow to Be MedicineWise while pregnant or breastfeeding – October 12, 2015
Australians are encouraged to be “medicinewise at all ages & life stages” during Be MedicineWise Week, October 12-18, 2015. The campaign kicked-off today with a focus on pregnancy and breastfeeding, after a recent NPS Medicine Wise survey of Australian women who were pregnant or had a child 11 years or younger revealed 33 per cent…
Read MoreTGA recommendation to reschedule codeine analgesics to S4 in June 2016
The Therapeutic Goods Administration’s (TGA) Advisory Committee on Medicines Scheduling has made an interim recommendation to reschedule codeine-containing products from S3 (Pharmacist Only Medicine) to S4 (Prescription Only Medicine) from June 2016. The decision is predicated on risk dependence and the adverse effects of codeine-based products compared to newly released forms of ibuprofen and paracetamol…
Read More